
Phospholipidosis (PLD), a cellular adverse effect that is, among others, caused by numerous cationic amphiphilic drugs. Interest is raised within pharma discovery to predict this phenomenon, as it can impact the outcome of phenotypic cellular screens and significantly delay drug development processes. The development of accurate and validated machine learning models for predicting drug-induced PLD across different cell lines and research centers could provide a valuable early application tool for the pharmaceutical industry, potentially accelerating drug discovery and reducing the risk of late-stage failures. We provide here one of the largest datasets of repurposed drugs (5K+) tested for PLD induction on different cell lines. The data ser was used for assembly, curation, testing and ML model development. In addition, we provide the ChEMBL v34 based target-list for the 58 hit compounds, that induced PLD in two tested cell lines.
Machine Learning, Drug Discovery, repurposing, drug-induced PLD, phospholipidosis
Machine Learning, Drug Discovery, repurposing, drug-induced PLD, phospholipidosis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
